Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Valves

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Acute results of the ASCEND EV study: A new modality of parasternal extravascular implantable cardioverter-defibrillator therapy including antitachycardia pacing.

Heart rhythm·2025

Same author

Corrigendum to "The effect of cardiac rhythm on artificial intelligence-enabled ECG evaluation of left ventricular ejection fraction prediction in cardiac intensive care unit patients" Int J Cardiol. 2021 Sep 15;339:54-55.

International journal of cardiology·2021

Same author

Improved Multiscale Entropy Technique with Nearest-Neighbor Moving-Average Kernel for Nonlinear and Nonstationary Short-Time Biomedical Signal Analysis.

Journal of healthcare engineering·2018

Same author

Novel approaches for quantitative electrogram analysis for intraprocedural guidance for catheter ablation: A case of a patient with persistent atrial fibrillation.

Nuclear medicine and biomedical imaging·2018

Same author

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.

Oncogene·2010

Same author

Species differentiation in Caenorhabditis briggsae and Caenorhabditis elegans.

Journal of nematology·2009

Search research articles

Related Experiment Video

Updated: Jun 30, 2026

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

The implantable cardioverter defibrillator.

M Glikson¹, P A Friedman

¹Heart Institute, Sheba Medical Centre, Tel Aviv University, Tel Hashomer, Israel.

Lancet (London, England)

|April 12, 2001

Summary

Implantable cardioverter defibrillators (ICDs) are now standard for high-risk arrhythmia patients. Newer ICDs offer advanced pacing for heart failure and atrial arrhythmias, improving quality of life.

Area of Science:

Cardiology
Biomedical Engineering
Electrophysiology

Background:

Implantable cardioverter defibrillators (ICDs) have transitioned from last resort treatments to the gold standard for managing ventricular tachyarrhythmias.
High-risk patient populations include survivors of life-threatening arrhythmias and asymptomatic individuals with cardiac conditions predisposing them to such events.

Purpose of the Study:

To review the current role and advancements of implantable cardioverter defibrillators (ICDs) in managing cardiac arrhythmias and heart failure.
To highlight considerations for patient quality of life, potential drug-device interactions, and electromagnetic interference with ICDs.

Main Methods:

Review of current literature and clinical guidelines regarding implantable cardioverter defibrillators (ICDs).

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Related Experiment Videos

Last Updated: Jun 30, 2026

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Implantation of Total Artificial Heart in Congenital Heart Disease

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Discussion of technological advancements in ICDs, including biventricular pacing capabilities.

Main Results:

Implantable cardioverter defibrillators (ICDs) are crucial for patients at high risk of ventricular tachyarrhythmias.
Patient quality of life, drug interactions, and electromagnetic interference are key considerations for ICD management.
Advanced ICDs offer dual-chamber pacing and biventricular pacing for atrial arrhythmias and congestive heart failure.

Conclusions:

Implantable cardioverter defibrillators (ICDs) are essential for preventing sudden cardiac death in high-risk individuals.
Comprehensive patient management requires attention to drug interactions, environmental electromagnetic interference, and quality of life.
Modern ICDs provide expanded therapeutic options beyond ventricular arrhythmia treatment, including heart failure management.